In the original article, there was a mistake in Figures 1, 3, 5 as published. In Figure 1A, one set of in vivo imaging pictures for Tan IIA-M and Tan IIA-H group were incorrectly used for the representative pictures, accompanying with the corresponding quantitative picture in Figure 1B. In Figure 3A, the picture for Tan IIA (5 μM) group was incorrectly used for the representative picture, accompanying with the corresponding quantitative picture in Figure 3B. In Figure 3E, the picture for Tan IIA (10 μM, 0 h) group was incorrectly used for the representative picture. In Figure 5A, the immunohistochemical picture for Snail (Tan IIA-M group) was incorrectly used for the representative picture. The corrected Figures 1, 3, 5 appear below.
FIGURE 1
FIGURE 3
FIGURE 5
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Statements
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Summary
Keywords
tanshinone IIA, colorectal cancer, epithelial-to-mesenchymal transition, β-arrestin1, β-catenin signaling pathway
Citation
Song Q, Yang L, Han Z, Wu X, Li R, Zhou L, Liu N, Sui H, Cai J, Wang Y, Ji Q and Li Q (2022) Corrigendum: Tanshinone IIA Inhibits Epithelial-to-Mesenchymal Transition Through Hindering β-Arrestin1 Mediated β-Catenin Signaling Pathway in Colorectal Cancer. Front. Pharmacol. 13:929656. doi: 10.3389/fphar.2022.929656
Received
27 April 2022
Accepted
06 June 2022
Published
01 July 2022
Volume
13 - 2022
Edited and reviewed by
Yue Liu, Xiyuan Hospital, China
Updates
Copyright
© 2022 Song, Yang, Han, Wu, Li, Zhou, Liu, Sui, Cai, Wang, Ji and Li.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Qing Ji, ttt99118@hotmail.com; Qi Li, qili@shutcm.edu.cn
†These authors have contributed equally to this work
This article was submitted to Ethnopharmacology, a section of the journal Frontiers in Pharmacology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.